Cargando…

Dynamics of type IV collagen 7S fragment on eradication of HCV with direct antiviral agents: Prognostic and metabolomic impacts

BACKGROUND: Liver fibrosis is one of the cardinal clinical features of chronic hepatitis C (CHC). However, the mechanisms underlying the evolution and reversion of liver fibrosis after hepatitis C virus (HCV) eradication and their relationship with clinical outcomes and metabolic alterations are not...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yamataka, Karin, Chu, Po-sung, Koda, Yuzo, Taniki, Nobuhito, Morikawa, Rei, Yoshida, Aya, Noguchi, Fumie, Kasuga, Ryosuke, Tabuchi, Takaya, Ebinuma, Hirotoshi, Kanai, Takanori, Nakamoto, Nobuhiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9612469/ https://www.ncbi.nlm.nih.gov/pubmed/36301899 http://dx.doi.org/10.1371/journal.pone.0276925

Ejemplares similares

Vulnerability to recurrent episodes of acute decompensation/acute-on-chronic liver failure characterizes those triggered by indeterminate precipitants in patients with liver cirrhosis
por: Hoshi, Hitomi, et al.
Publicado: (2021)

IL-15-producing splenic B cells play pathogenic roles in the development of autoimmune hepatitis
por: Fujimori, Sota, et al.
Publicado: (2023)

CLIF‐C Organ Failure Score and Liver Volume Predict Prognosis in Steroid‐Treated Severe Acute Autoimmune Hepatitis
por: Ikura, Akihiko, et al.
Publicado: (2020)

Clinical implications with tolvaptan on monitored bioimpedance-defined fluid status in patients with cirrhotic ascites: an observational study
por: Shiba, Shunsuke, et al.
Publicado: (2020)

Liver Fibrosis Markers Improve Prediction of Outcome in Non‐Acetaminophen‐Associated Acute Liver Failure
por: Ugamura, Aya, et al.
Publicado: (2018)

Bone marrow-derived macrophages distinct from tissue-resident macrophages play a pivotal role in Concanavalin A-induced murine liver injury via CCR9 axis
por: Amiya, Takeru, et al.
Publicado: (2016)

Dual effects of the Nrf2 inhibitor for inhibition of hepatitis C virus and hepatic cancer cells
por: Murakami, Yuko, et al.
Publicado: (2018)

CCR9 axis inhibition enhances hepatic migration of plasmacytoid DCs and protects against liver injury
por: Koda, Yuzo, et al.
Publicado: (2022)

Myeloid TLR4 signaling promotes post-injury withdrawal resolution of murine liver fibrosis
por: Takimoto, Yoichi, et al.
Publicado: (2023)

On-treatment decrease of NKG2D correlates to early emergence of clinically evident hepatocellular carcinoma after interferon-free therapy for chronic hepatitis C
por: Chu, Po-sung, et al.
Publicado: (2017)

Genotype-Associated Differential NKG2D Expression on CD56+CD3+ Lymphocytes Predicts Response to Pegylated-Interferon/ Ribavirin Therapy in Chronic Hepatitis C
por: Chu, Po-sung, et al.
Publicado: (2015)

Hepatic Adenosine Triphosphate Reduction Through the Short‐Chain Fatty Acids–Peroxisome Proliferator‐Activated Receptor γ–Uncoupling Protein 2 Axis Alleviates Immune‐Mediated Acute Hepatitis in Inulin‐Supplemented Mice
por: Yamaguchi, Akihiro, et al.
Publicado: (2021)

Concurrent de novo Thymoma-associated Paraneoplastic Type 1 Autoimmune Hepatitis and Pure Red Cell Aplasia after Thymectomy: A Case Report and Literature Review
por: Sakata, Rie, et al.
Publicado: (2022)

CD8(+) tissue-resident memory T cells promote liver fibrosis resolution by inducing apoptosis of hepatic stellate cells
por: Koda, Yuzo, et al.
Publicado: (2021)

Acetaldehyde exposure underlies functional defects in monocytes induced by excessive alcohol consumption
por: Shiba, Shunsuke, et al.
Publicado: (2021)

Detection of bacterial DNA by in situ hybridization in patients with decompensated liver cirrhosis
por: Usui, Shingo, et al.
Publicado: (2017)

Progressive liver failure induced by everolimus for renal cell carcinoma in a 58-year-old male hepatitis B virus carrier
por: Mizuno, Shinta, et al.
Publicado: (2013)

Prominent Steatosis with Hypermetabolism of the Cell Line Permissive for Years of Infection with Hepatitis C Virus
por: Sugiyama, Kazuo, et al.
Publicado: (2014)

IL-22-Producing RORγt-Dependent Innate Lymphoid Cells Play a Novel Protective Role in Murine Acute Hepatitis
por: Matsumoto, Atsuhiro, et al.
Publicado: (2013)

Bacteriophage therapy against pathological Klebsiella pneumoniae ameliorates the course of primary sclerosing cholangitis
por: Ichikawa, Masataka, et al.
Publicado: (2023)

Utility of the SARC-F Questionnaire for Sarcopenia Screening in Patients with Chronic Liver Disease: A Multicenter Cross-Sectional Study in Japan
por: Hanai, Tatsunori, et al.
Publicado: (2021)

Sitafloxacin for Third-Line Helicobacter pylori Eradication: A Systematic Review
por: Nishizawa, Toshihiro, et al.
Publicado: (2021)

Macrophages and Dendritic Cells Emerge in the Liver during Intestinal Inflammation and Predispose the Liver to Inflammation
por: Mikami, Yohei, et al.
Publicado: (2014)

Role of Toll-Like Receptors in Immune Activation and Tolerance in the Liver
por: Nakamoto, Nobuhiro, et al.
Publicado: (2014)

Enrichment of type I interferon signaling in colonic group 2 innate lymphoid cells in experimental colitis
por: Irie, Emi, et al.
Publicado: (2022)

Prediction of Effect of Pegylated Interferon Alpha-2b plus Ribavirin Combination Therapy in Patients with Chronic Hepatitis C Infection
por: Takayama, Tetsuro, et al.
Publicado: (2011)

Lymphoma Remission by Interferon-Free HCV Eradication Without Chemotherapy
por: Lim, Lucy Y., et al.
Publicado: (2015)

Clinical features of cardiac nodularity-like appearance induced by Helicobacter pylori infection
por: Nishizawa, Toshihiro, et al.
Publicado: (2020)

Endoscopic diagnosis for colorectal sessile serrated lesions
por: Nishizawa, Toshihiro, et al.
Publicado: (2021)

Risk Factors for Prolonged Hospital Stay after Endoscopy
por: Nishizawa, Toshihiro, et al.
Publicado: (2021)

Liver steatosis and dyslipidemia after HCV eradication by direct acting antiviral agents are synergistic risks of atherosclerosis
por: Kawagishi, Naoki, et al.
Publicado: (2018)

Telomere Length Increase in HIV/HCV-Coinfected Patients with Cirrhosis after HCV Eradication with Direct-Acting Antivirals (†)
por: Molina-Carrión, Silvia, et al.
Publicado: (2020)

Eradication of HCV in Renal Transplant Recipients and Its Effects on Quality of Life
por: Sabbatini, Massimo, et al.
Publicado: (2018)

Special Issue “Chronic HCV Infection: Clinical Advances and Eradication Perspectives”
por: Liberto, Maria Carla, et al.
Publicado: (2022)

Stratification of Hepatocellular Carcinoma Risk Following HCV Eradication or HBV Control
por: Nahon, Pierre, et al.
Publicado: (2021)

Eradication of HCV Infection with the Direct-Acting Antiviral Therapy in Renal Allograft Recipients
por: Armando, Calogero, et al.
Publicado: (2019)

Progress in eradication of HCV in HIV positive patients with significant liver fibrosis in Vienna
por: Steiner, Sebastian, et al.
Publicado: (2017)

Management of patients with pre-therapeutic advanced liver fibrosis following HCV eradication
por: Nahon, Pierre, et al.
Publicado: (2019)

HCV eradication with IFN-based therapy does not completely restore gene expression in PBMCs from HIV/HCV-coinfected patients
por: Brochado, Óscar, et al.
Publicado: (2021)

Immunological and Clinical Impact of DAA-Mediated HCV Eradication in a Cohort of HIV/HCV Coinfected Patients: Monocentric Italian Experience
por: Marino, Andrea, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_77h5m9etveiedut5f123letr1s